Beckman Coulter Diagnostics receives CE-Mark under IVDR for its Access p-Tau217 assay: Brea, California Wednesday, July 8, 2026, 11:00 Hrs [IST] Beckman Coulter Diagnostics, a glo ...
Beckman Coulter Diagnostics has expanded its Alzheimer’s disease testing portfolio with a CE-marked blood test for p-Tau217 ...
Beckman Coulter Diagnostics, a global leader in clinical diagnostics and a Danaher company, today announced it received CE ...
Silver Bow Mining Corp. (NYSE American: SBMT) (“Silver Bow Mining” or the “Company”) announced today the assay results from the first two drill holes of its 25,000-foot surface diamond drilling ...
Liquid biopsy is rapidly transforming how cancer is detected, monitored, and treated. While major progress has been made in identifying tumour-derived signals in blood, the central challenge now is ...
A paper published in the journal Biomarker Research by a cross-university team led by Queen Mary University of London ...
Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...
Dr. Neerja Bhatla emphasizes the necessity for India to shift towards HPV DNA-based screening to eliminate cervical cancer ...
Highly sensitive next-generation sequencing-based MRD testing will identify eligible patients with T-cell malignancies ...
US non-profit Food System Innovations has launched a Sustainable Protein Action Lab to bridge the research funding gap and ...
The increasing globalization of drug development programs has driven a growing need for rigorous cross-validation of bioanalytical assays across multiple laboratory sites. As bioanalytical methods ...
Researchers developed a forensic proteomics workflow that identified the species origin of hair using protein biomarkers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results